About 57 people are diagnosed with breast cancer every day in Australia, with instances having grown over the past decade.…
In 2023, the emerging cancer diagnostics market is estimated to be valued at over $23 billion. Everything is fair game…
Precision diagnostics company INOVIQ (ASX: IIQ) has achieved noteworthy results from an independent clinical validation study of its SubB2M/CA15-3 test…
Treating cancer is a primary goal of many biotech companies, but for any treatment to begin, physicians need a definitive…